Understanding the US Biosecure Act's Impact on the Indian Pharma Industry

Tuesday, 10 September 2024, 01:13

The US Biosecure Act passed by the House aims to reshape the Indian pharma industry landscape by prohibiting US drugmakers from engaging with specific Chinese companies. This act is expected to boost Indian CDMOs as US firms shift manufacturing away from China, creating significant growth opportunities. With the CDMO market outpacing global pharmaceutical growth, the Indian pharma sector is poised for a transformative shift due to this legislative change.
Moneycontrol
Understanding the US Biosecure Act's Impact on the Indian Pharma Industry

Overview of the US Biosecure Act

The US Biosecure Act passed on September 9, aims to limit US biopharmaceutical reliance on China. This legislative shift prohibits collaborations with five Chinese companies to foster growth in US and Indian markets.

Implications for Indian CDMO Players

  • Indian CDMO companies like Divi's Labs and Laurus Labs are set to benefit from increased inquiries as US firms seek alternatives to Chinese manufacturers.
  • The act impacts up to 120 US biopharmaceutical drugs, creating opportunities for Indian players.

Market Growth and Forecast

The CDMO market is growing, driven by biotech companies needing support without heavy investments in infrastructure. The US Biosecure Act positions India as a favorable destination for outsourcing.

  1. India's CDMO market projected to grow from $19.63 billion in 2023 to $44.69 billion by 2029.
  2. Supported by government incentives and increasing foreign investment.

This act marks a pivotal moment for the Indian pharma sector, as the industry braces for substantial growth amid a shifting global landscape.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe